Lleida.net shareholders to meet on Monday to approve its IP

Madrid, 11 September.- Lleida.net General Shareholders' Meeting will meet online, next Monday, to discuss and, where appropriate, to approve the company's listing on the OTC Markets Group in New York.

On July 31, the Board of Directors of the listed company approved to request its shareholders authorization to go public in New York.

If the listing is approved, the Lleida.net shares would be marketed in the OTCQX segment of the OTC, which brings together nearly 500 international companies and capitalizes 1.4 trillion dollars.

Lleida.net, which has revalued  in Euronext Growth and in BME Growth above 800% this year thinks that being listed d on the United States market will make it easier for a greater number of international investors to access the company's capital.

Currently, Lleida.net has been listed in the Growth segment of BME since 2015 (former MAB) and in the Growth segment of Euronext, in Paris, since the end of 2018.

Throughout 2020, the company has established itself as the most liquid one in the Spanish alternative market, with accumulated trading volumes of more than 100 million euros, over 50 times more than the set of those registered in 2019.

Lleida.net, which has established itself in 2020 as the main provider of services for digital signature and contracting processes and registered electronic notification, plans to start marketing the United States market next year.

The company already has an international portfolio of over 185 patents, granted by the intellectual property authorities of the United States, the European Union, China, Russia, India, Mexico, Japan, Colombia, Argentina, Peru, South Africa, Nigeria, Australia or New Zealand.

In June, it distributed its first-ever dividends.